Related Experiment Video
Updated: Mar 25, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Are Human Tyrosinase and Related Proteins Suitable Targets for Melanoma Therapy?
Elina Buitrago, Renaud Hardré, Romain Haudecoeur
1ISM2 UMR CNRS 7313, Centre Scientifique de Saint Jérôme, Aix Marseille Université, 13397, Marseille cedex 20, France. marius.reglier@univ-amu.fr.
Abstract:
Among the human copper-containing monooxygenases, Tyrosinase (Ty) is an important enzyme involved in the determinant step of the biosynthetic pathway of melanin pigment. In this pathway, Ty catalyzes the tyrosine monooxygenation into L-DOPA-quinone, which is the precursor of the skin pigment melanin. Ty inhibitors/activators are a well-established approach for controlling in vivo melanin production, so their development has a huge economical and industrial impact. Moreover, recent publications highlight that targeting tyrosinase with inhibitors/activators to treat melanogenesis disorders is one of many possible approaches, due to the complex biochemical reaction involved in the melanin synthesis.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Mitogens and the Cell Cycle

